These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30776369)

  • 1. Molecular aspects of depression: A review from neurobiology to treatment.
    Villas Boas GR; Boerngen de Lacerda R; Paes MM; Gubert P; Almeida WLDC; Rescia VC; de Carvalho PMG; de Carvalho AAV; Oesterreich SA
    Eur J Pharmacol; 2019 May; 851():99-121. PubMed ID: 30776369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurobiology of depression and antidepressant action.
    Willner P; Scheel-Krüger J; Belzung C
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 1):2331-71. PubMed ID: 23261405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurobiology of depression: An integrated view.
    Dean J; Keshavan M
    Asian J Psychiatr; 2017 Jun; 27():101-111. PubMed ID: 28558878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of glutamate signaling in preclinical and/or mechanistic models of depression.
    Tokita K; Yamaji T; Hashimoto K
    Pharmacol Biochem Behav; 2012 Feb; 100(4):688-704. PubMed ID: 21536063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative physiology of depression and antidepressant drug action: implications for serotonergic mechanisms of action and novel therapeutic strategies for treatment of depression.
    Hale MW; Raison CL; Lowry CA
    Pharmacol Ther; 2013 Jan; 137(1):108-18. PubMed ID: 23017938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobiology of resilience in depression: immune and vascular insights from human and animal studies.
    Dudek KA; Dion-Albert L; Kaufmann FN; Tuck E; Lebel M; Menard C
    Eur J Neurosci; 2021 Jan; 53(1):183-221. PubMed ID: 31421056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular neurobiology of depression.
    Krishnan V; Nestler EJ
    Nature; 2008 Oct; 455(7215):894-902. PubMed ID: 18923511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurobiology of depression: new data].
    Lanfumey L; Hamon M
    Therapie; 2005; 60(5):431-40. PubMed ID: 16433009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Neurobiology and Promising New Treatment in Depression.
    Jeon SW; Kim YK
    Int J Mol Sci; 2016 Mar; 17(3):381. PubMed ID: 26999106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions.
    Fornaro M; Solmi M; Veronese N; De Berardis D; Buonaguro EF; Tomasetti C; Perna G; Preti A; Carta MG
    Int Rev Psychiatry; 2017 Oct; 29(5):425-435. PubMed ID: 28681620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood depressive disorders.
    Wesselhoeft RT
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
    Leblé N; Radon L; Rabot M; Godart N
    Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of depression and neuroplasticity: assessing drug action in relation to behavior and neurogenesis.
    Xu Y; Barish PA; Pan J; Ogle WO; O'Donnell JM
    Methods Mol Biol; 2012; 829():103-24. PubMed ID: 22231809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The promise of ketamine for treatment-resistant depression: current evidence and future directions.
    DeWilde KE; Levitch CF; Murrough JW; Mathew SJ; Iosifescu DV
    Ann N Y Acad Sci; 2015 May; 1345(1):47-58. PubMed ID: 25649308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Depression and treatment. Apoptosis, neuroplasticity and antidepressants].
    Arantes-Gonçalves F; Coelho R
    Acta Med Port; 2006; 19(1):9-20. PubMed ID: 16987439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of G-protein coupled receptor signalling underpinning neurobiology of mood disorders and depression.
    Grammatopoulos DK
    Mol Cell Endocrinol; 2017 Jul; 449():82-89. PubMed ID: 28229904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic plasticity model of therapeutic sleep deprivation in major depression.
    Wolf E; Kuhn M; Normann C; Mainberger F; Maier JG; Maywald S; Bredl A; Klöppel S; Biber K; van Calker D; Riemann D; Sterr A; Nissen C
    Sleep Med Rev; 2016 Dec; 30():53-62. PubMed ID: 26803484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A brief history of antidepressant drug development: from tricyclics to beyond ketamine.
    Pereira VS; Hiroaki-Sato VA
    Acta Neuropsychiatr; 2018 Dec; 30(6):307-322. PubMed ID: 29388517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.